Literature DB >> 19769977

Illicit anabolic-androgenic steroid use.

Gen Kanayama1, James I Hudson, Harrison G Pope.   

Abstract

The anabolic-androgenic steroids (AAS) are a family of hormones that includes testosterone and its derivatives. These substances have been used by elite athletes since the 1950s, but they did not become widespread drugs of abuse in the general population until the 1980s. Thus, knowledge of the medical and behavioral effects of illicit AAS use is still evolving. Surveys suggest that many millions of boys and men, primarily in Western countries, have abused AAS to enhance athletic performance or personal appearance. AAS use among girls and women is much less common. Taken in supraphysiologic doses, AAS show various long-term adverse medical effects, especially cardiovascular toxicity. Behavioral effects of AAS include hypomanic or manic symptoms, sometimes accompanied by aggression or violence, which usually occur while taking AAS, and depressive symptoms occurring during AAS withdrawal. However, these symptoms are idiosyncratic and afflict only a minority of illicit users; the mechanism of these idiosyncratic responses remains unclear. AAS users may also ingest a range of other illicit drugs, including both "body image" drugs to enhance physical appearance or performance, and classical drugs of abuse. In particular, AAS users appear particularly prone to opioid use. There may well be a biological basis for this association, since both human and animal data suggest that AAS and opioids may share similar brain mechanisms. Finally, AAS may cause a dependence syndrome in a substantial minority of users. AAS dependence may pose a growing public health problem in future years but remains little studied. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769977      PMCID: PMC2883629          DOI: 10.1016/j.yhbeh.2009.09.006

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  211 in total

1.  Anabolic steroid abuse and renal cell carcinoma.

Authors:  G Martorana; S Concetti; F Manferrari; S Creti
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

2.  Multiple drug use and dietary restraint in a Mr. Universe competitor: psychobiological effects.

Authors:  C Wilson-Fearon; A C Parrott
Journal:  Percept Mot Skills       Date:  1999-04

3.  Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.

Authors:  S Grinspoon; C Corcoran; T Stanley; A Baaj; N Basgoz; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  Anabolic androgenic steroids and suicide.

Authors:  I Thiblin; B Runeson; J Rajs
Journal:  Ann Clin Psychiatry       Date:  1999-12       Impact factor: 1.567

5.  Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.

Authors:  I Thiblin; A Finn; S B Ross; C Stenfors
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Nalbuphine hydrochloride dependence in anabolic steroid users.

Authors:  J D Wines; A J Gruber; H G Pope; S E Lukas
Journal:  Am J Addict       Date:  1999

7.  Evolving ideals of male body image as seen through action toys.

Authors:  H G Pope; R Olivardia; A Gruber; J Borowiecki
Journal:  Int J Eat Disord       Date:  1999-07       Impact factor: 4.861

8.  Psychiatric and medical effects of anabolic-androgenic steroid use in women.

Authors:  A J Gruber; H G Pope
Journal:  Psychother Psychosom       Date:  2000       Impact factor: 17.659

9.  Factors associated with adolescent use of doping agents: anabolic-androgenic steroids.

Authors:  A M Kindlundh; D G Isacson; L Berglund; F Nyberg
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

10.  Psychosexual effects of three doses of testosterone cycling in normal men.

Authors:  W R Yates; P J Perry; J MacIndoe; T Holman; V Ellingrod
Journal:  Biol Psychiatry       Date:  1999-02-01       Impact factor: 13.382

View more
  58 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

Review 3.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

4.  Ameliorative Effects of Endurance Exercise with Two Different Intensities on Nandrolone Decanoate-Induced Neurodegeneration in Rats: Involving Redox and Apoptotic Systems.

Authors:  Siyavash Joukar; Reza Vahidi; Alireza Farsinejad; Majid Asadi-Shekaari; Beydolah Shahouzehi
Journal:  Neurotox Res       Date:  2017-01-31       Impact factor: 3.911

5.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

Review 6.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

7.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

8.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

9.  Mood Symptoms in Steroid Users: The Unexamined Role of Concurrent Stimulant Use.

Authors:  Pilar M Sanjuan; James L Langenbucher; Tom Hildebrandt
Journal:  J Subst Use       Date:  2015-09-18

10.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.